150 related articles for article (PubMed ID: 9841879)
1. Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.
Xing R; Mason RW
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):667-73. PubMed ID: 9841879
[TBL] [Abstract][Full Text] [Related]
2. Labelling of cysteine proteinases in purified lysosomes.
Wilcox D; Mason RW
Biochem Soc Trans; 1989 Dec; 17(6):1080-1. PubMed ID: 2628091
[No Abstract] [Full Text] [Related]
3. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
Crawford C; Mason RW; Wikstrom P; Shaw E
Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
[TBL] [Abstract][Full Text] [Related]
4. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
5. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.
Mason RW; Wilcox D; Wikstrom P; Shaw EN
Biochem J; 1989 Jan; 257(1):125-9. PubMed ID: 2537618
[TBL] [Abstract][Full Text] [Related]
6. The use of benzyloxycarbonyl[125I]iodotyrosylalanyldiazomethane as a probe for active cysteine proteinases in human tissues.
Mason RW; Bartholomew LT; Hardwick BS
Biochem J; 1989 Nov; 263(3):945-9. PubMed ID: 2597135
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.
Bednarski E; Lynch G
J Neurochem; 1996 Nov; 67(5):1846-55. PubMed ID: 8863489
[TBL] [Abstract][Full Text] [Related]
8. [New specific inhibitor design by computer-graphics of protease structure].
Katunuma N
Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2474-81. PubMed ID: 9366234
[No Abstract] [Full Text] [Related]
9. Synthesis and properties of Cbz-Phe-Arg-CHN2 (benzyloxycarbonylphenylalanylarginyldiazomethane) as a proteinase inhibitor.
Zumbrunn A; Stone S; Shaw E
Biochem J; 1988 Mar; 250(2):621-3. PubMed ID: 3355540
[TBL] [Abstract][Full Text] [Related]
10. Interaction of lysosomal cysteine proteinases with alpha 2-macroglobulin: conclusive evidence for the endopeptidase activities of cathepsins B and H.
Mason RW
Arch Biochem Biophys; 1989 Sep; 273(2):367-74. PubMed ID: 2476070
[TBL] [Abstract][Full Text] [Related]
11. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
Wikstrom P; Kirschke H; Stone S; Shaw E
Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
[TBL] [Abstract][Full Text] [Related]
12. Quantification of cathepsins B and L in cells.
Xing R; Addington AK; Mason RW
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):499-505. PubMed ID: 9601080
[TBL] [Abstract][Full Text] [Related]
13. Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages.
Hara K; Kominami E; Katunuma N
FEBS Lett; 1988 Apr; 231(1):229-31. PubMed ID: 3360127
[TBL] [Abstract][Full Text] [Related]
14. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia.
Seyfried DM; Veyna R; Han Y; Li K; Tang N; Betts RL; Weinsheimer S; Chopp M; Anagli J
Brain Res; 2001 May; 901(1-2):94-101. PubMed ID: 11368955
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.
Bednarski E; Ribak CE; Lynch G
J Neurosci; 1997 Jun; 17(11):4006-21. PubMed ID: 9151717
[TBL] [Abstract][Full Text] [Related]
16. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
Montaser M; Lalmanach G; Mach L
Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
[TBL] [Abstract][Full Text] [Related]
17. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
[TBL] [Abstract][Full Text] [Related]
18. Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.
Kirschke H; Shaw E
Biochem Biophys Res Commun; 1981 Jul; 101(2):454-8. PubMed ID: 7306089
[No Abstract] [Full Text] [Related]
19. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation.
Buttle DJ; Saklatvala J
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):657-61. PubMed ID: 1445226
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.
Pagano M; Esnard F; Engler R; Gauthier F
Biochem J; 1984 May; 220(1):147-55. PubMed ID: 6547604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
